Point-counterpoint: Are we overtreating patients with mild ulcerative colitis?
VA Ann Arbor Health Services Research & Development Center for Clinical Management Research, Ann Arbor, MI, United States; Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States. Electronic address: awaljee@med.umich.edu.
Akbar K
AK
Waljee
Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
Ryan W
RW
Stidham
Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
Peter D R
PD
Higgins
VA Ann Arbor Health Services Research & Development Center for Clinical Management Research, Ann Arbor, MI, United States; Division of General Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
Sandeep
S
Vijan
VA Ann Arbor Health Services Research & Development Center for Clinical Management Research, Ann Arbor, MI, United States; Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
Sameer D
SD
Saini
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D003082:Colectomy; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000601:surgery; D015179:Colorectal Neoplasms / Q000517:prevention & control*; D006801:Humans; D060046:Maintenance Chemotherapy; D008297:Male; D055118:Medication Adherence; D019804:Mesalamine / Q000008:administration & dosage*; D012720:Severity of Illness Index
D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine
5-ASA; Inflammatory Bowel Disease; Mesalamine; Ulcerative colitis